Loading...
HOME2023-01-22T13:43:33-07:00

“Damn, there is so much great knowledge out there. Did you know that “BOOKS” are full of smart?? No, I mean like life changing, I-wish-I-knew-that-years-ago type stuff.

I know that I was waaaayyy late to the game figuring it out. And I know that a lot of you are too busy to read as much as you ‘should’. And that is why you need me.

I still remember how it started for me. It started in June of 2008. After 11  years …..Click to continue

Mortgage Today (PM) - 10/27/26 {{catlist}}
October 27, 2026 READ MORE **WTMS Blog Today = What's up in Mortgage Today (PM) - 10/23/2026** Mortgage rates delivered their best daily performance since August 2025 this week as technology stock turmoil sent investors scrambling into the safety of Treasury bonds. The 10-year yield plummeted 159 basis points on Thursday alone, with UMBS 6.0 climbing nearly 70 basis points to 99.55 as flight-to-safety dynamics overwhelmed concerns about persistent inflation and elevated oil prices. Artificial intelligence sector weakness, particularly pressure on companies like Coreweave facing funding uncertainties, triggered broad equity selloffs that fundamentally shifted bond market demand. Mortgage origination margins improved noticeably as secondary markets tightened spreads, offering meaningful relief after weeks of constrained gain-on-sale margins. The rally's staying power depends entirely on whether technology credit concerns persist or stabilize, creating genuine uncertainty for locking strategy into early November. President Trump signed a sweeping housing executive order Thursday targeting mortgage insurance cancellation, refinance costs, and GSE fee structures through the FHFA. The order directs proactive mortgage insurance cancellation for eligible borrowers based on current property values, though the pilot applies only to loans originated after the program begins, limiting immediate impact on existing homeowners. Title insurance waiver programs become permanent, potentially saving $500 to $1,500 per refinance while loan-level price adjustments face potential reduction on qualifying rate-reduction refis. However, critics note the proposal favors existing homeowners over purchase borrowers, as savings flow primarily to refinancing and mortgage insurance cancellation rather than addressing home price affordability. The MBA's competing affordability roadmap proposes reducing credit score reporting requirements, lowering FHA insurance premiums, and streamlining refinancing across both GSEs. Origination volume projections worsened measurably this week with the MBA forecasting 2027 total single-family mortgage volume declining 5% to just under $2 trillion, down from $2.1 trillion expected in 2026. Purchase originations face only modest 0.8% growth while refinance volume collapses 17% to $571 billion as rising rates throughout October destroyed refinance economics for the vast majority of borrowers. September funding volume declined 15% year-over-year according to proprietary application data, with retail declining 7% month-over-month despite a 30-year funded rate of 6.58%. Mortgage applications fell another 2.7% week-over-week as rates climbed to 7.5%, their highest level in nearly three years, pushing adjustable-rate mortgage adoption to 10.5% of applications. September prepayment speeds slowed sharply with Fannie Mae speeds falling 7% month-over-month to 6.7 CPR as only 0.5% of mortgages remained economically attractive to refinance. Home sellers outnumber buyers by 63%, the widest gap since 2013, creating a buyer's market across 41 of 50 major metros while just five remain seller-favored. Existing home sales rose 1.5% month-over-month to 3.99 million annually, but still trail year-ago levels by 2.2%, with inventory climbing 4.6% year-over-year to 1.6 million homes representing 4.8 months supply. The median existing home price reached $417,500, marking the 39th consecutive month of year-over-year gains despite affordability pressures crushing demand. Even borrowers willing to put down 20% face an affordability gap, with the median home requiring $90,191 in annual income versus the $79,534 average wage, creating a gap of nearly $11,000. Homes became less affordable than historical averages in 570 of 583 counties analyzed, demonstrating the breadth of the affordability crisis across virtually every market. Wire fraud and defect risk reached troubling levels in the third quarter with FundingShield's analytics showing 45.9% of monitored transactions carrying material wire and title-related risks across a $108.7 billion portfolio. Problematic transactions averaged 2.2 issues each, with 47.8% involving closing protection letter discrepancies, 6% involving wire-instruction defects, and 1.6% involving licensing irregularities. GSE repurchase activity increased 19.5% in Q2'26 with 1,401 loans totaling $465.2 million in UPB repurchased, with loans from Q3'25 and Q4'25 accounting for 46.5% of activity. Rocket Mortgage, United Wholesale Mortgage, and Lakeview Loan Servicing represented the three largest originators by repurchase share at 9.7%, 5.4%, and 2.4% respectively. Fannie Mae also expanded occupancy verification requirements effective November 13, requiring automated valuation model screening to flag potentially inaccurate designations before purchase. **Locking vs Floating** Tech stock weakness created genuine safe-haven demand for bonds, but the rally's continuation depends on whether semiconductor and AI-related credit concerns spread to the broader market or stabilize. Intraday volatility remained elevated as options expiration and thin Friday trading exaggerated moves in both directions, though closing prices held near session highs. Rates appear to have found support in the 5.05% to 5.10% range this week, but another tech recovery could quickly send yields back toward the 5.27% to 5.34% resistance levels recently tested. Lenders should avoid overcommitting to aggressive repricing until Monday's opening establishes confirmation of either continued safe-haven demand or profit-taking reversals. **Today's Events** Import prices September: 1.1% vs 0.8% forecast Industrial Production September: 0.7% vs 0.4% expected Consumer Sentiment October (preliminary): 47.6 vs 48.1 prior Existing Home Sales September: 3.99M vs 3.95M forecast **Bond Pricing** **UMBS 30 yr** | Coupon | Price | Intra-Day Change | **GNMA 30 yr** | Coupon | Price | Intra-Day Change | **Treasuries** | Term | Yield | Price | Intra-Day Yield Change |

Market Data Mortgage Today (AM) - 10/27/26 {{catlist}}
October 27, 2026 READ MORE **WTMS Blog Today = What's up in Mortgage Today (AM) - 10/27/2026** The mortgage industry is stuck in a vise: rates near 5 percent keep borrowers on the sidelines while builder confidence hits its lowest level since 2012. Non-QM and ARM products are filling the volume gap as loan officers navigate a market that rewards speed and flexibility over traditional conforming strategies. UMBS securities weakened mid-week but recovered, reflecting the tension between safe-haven demand and persistent inflation concerns tied to elevated oil prices above $100 per barrel. Capital markets remain cautious ahead of this week's FOMC decision, with traders pricing roughly an 80 percent probability of a December rate hike despite Fed leadership signaling no urgency for an immediate move. President Trump's executive order directing lower GSE mortgage insurance and title costs could eventually ease refinance friction, though implementation timelines remain uncertain and wide industry interpretation persists. Loan officers and branch managers continue to face retention pressures as production economics tighten and alternative channels—wholesale, correspondent, and broker platforms—attract talent with lower cost structures and delegation models. **Locking vs Floating** Borrowers considering locks should act decisively at current levels, as mortgage rates remain structurally sticky above 4.95 percent on the 10-year Treasury. Further rate relief appears constrained unless oil prices retreat sharply or Fed pivot signals emerge, making near-term float risk limited for most scenarios. Rate locks provide certainty in an otherwise volatile week heading into Wednesday's FOMC statement, particularly for closing-sensitive transactions. **Today's Events** September Durable Goods Orders (released, +1.8% vs. +1.9% forecast). August FHFA Housing Price Index. August S&P Case-Shiller Home Price Index. October Consumer Confidence. September New Home Sales. $70 billion 5-year Treasury note auction. **Bond Pricing** **UMBS 30 yr** | Coupon | Price | Intra-Day Change | **GNMA 30 yr** | Coupon | Price | Intra-Day Change | **Treasuries** | Term | Yield | Price | Intra-Day Yield Change |

Market Data Gene-Edited War Dogs in Body Armor: The $1.2 Billion Startup That Sounds Like Science Fiction {{catlist}}
October 27, 2026 READ MORE
 

Gene-Edited War Dogs in Body Armor: The $1.2 Billion Startup That Sounds Like Science Fiction

You probably didn't have "cloned war dogs in high-tech armor" on your 2027 bingo card, but here we are. Two billionaire tech founders just launched a startup that wants to genetically engineer elite military dogs, clone them, and outfit them with advanced battlefield equipment. It sounds like a rejected screenplay, except it's real, it's already raised $200 million, and the first gene-edited puppies are expected in about two years.

The Players Behind This Wild Idea

Warhound is the brainchild of Ben Lamm, who founded Colossal Biosciences (the company working to bring back woolly mammoths), and Palmer Luckey, the Oculus VR creator who now runs Anduril, a defense technology company. Lamm brings the genetic engineering expertise; Luckey brings the military hardware and software. Together, they've convinced investors that genetically optimized dogs in sensor-laden armor represent the future of military and law enforcement operations. The company is already valued at $1.2 billion before it's produced a single animal. That valuation tells you how seriously the defense and biotech worlds are taking this concept, even if it sounds like something from a Marvel movie.

How the Technology Actually Works

The process starts with collecting cells from proven working dogs—military dogs, police K9s, and first-responder animals that have demonstrated exceptional performance in real situations. Warhound's scientists will edit the genomes of these cells to remove genes associated with inherited health problems and potentially add genes that enhance desirable traits. Then they'll use cloning technology to create embryos that develop into puppies carrying those modifications. This isn't hypothetical science; the cloning part is established technology that's been used on pets and livestock for years. The gene-editing component uses CRISPR and related tools that are now standard in biotech labs. What's new is applying both techniques specifically to create optimized working dogs at scale.

The Health Improvements Come First

The initial gene edits will target inherited diseases that plague many dog breeds, especially the larger breeds commonly used in military and police work. Hip dysplasia, a painful joint condition, affects roughly 20 percent of German Shepherds and Belgian Malinois—the breeds most commonly used as working dogs. Other targets include heart conditions, certain cancers, and joint problems that force dogs into early retirement or cause chronic pain. Eliminating these conditions would genuinely improve animal welfare, extending working dogs' careers and quality of life. A military dog costs approximately $40,000 to $50,000 to acquire and train, so keeping them healthy and operational longer has real economic value beyond the moral argument. This is the least controversial part of Warhound's mission, and it's where the company will likely start.

The Performance Enhancements Are Where It Gets Complicated

Once the health issues are addressed, Warhound plans to move into enhancement territory—editing genes to improve speed, agility, endurance, and olfactory capability. The company has mentioned potentially incorporating wolf genes to boost certain traits. Wolves can sustain running speeds of about 35 miles per hour and have scent detection abilities that exceed even the best dog breeds. They also have different pain tolerance and pack behavior patterns. This is where the technology shifts from therapeutic to enhancement, from fixing problems to creating capabilities that don't exist in current dogs. It raises questions about what we're creating and why. Are we making better tools, or are we creating animals that exist primarily to serve human military objectives in ways that might compromise their welfare?

The Anduril Hardware Adds Another Layer

Palmer Luckey's Anduril isn't just an investor; the company will develop the physical and software systems these dogs will carry into the field. We're talking about advanced body armor designed specifically for canine anatomy, protective goggles that could include heads-up displays or low-light enhancement, and integrated sensor systems that feed battlefield awareness data to handlers and command centers. Current military dogs already wear some protective gear, but Anduril's track record suggests something far more sophisticated—think networked systems that turn each dog into a mobile sensor platform. The dog becomes both a biological operator and a piece of connected battlefield infrastructure. That integration could save human and canine lives by providing better situational awareness, but it also means these animals are being designed as weapons systems from the genome up.

The Timeline Is Surprisingly Close

Warhound expects its first gene-edited puppies in early 2027—roughly two years from now. That aggressive timeline is possible because both the cloning technology and the gene-editing tools already exist and have been proven in other applications. The company isn't inventing new science; it's combining established techniques in a new context. After those first puppies are born, there will be years of training and evaluation to see if the genetic modifications translate into real-world performance improvements. A military working dog typically requires 18 to 24 months of training before deployment, so we're looking at operational animals around 2029 at the earliest. That's still remarkably fast for a technology that didn't exist as a company until 2026.

The Potential Civilian Benefits Are Real

While Warhound's focus is military and law enforcement, the technology could have significant civilian applications. Search-and-rescue dogs that are healthier, have longer careers, and possess enhanced scent detection could save more lives in disaster scenarios. Detection dogs used in conservation work, at borders for agricultural inspection, or in medical settings for disease detection could all benefit from genetic improvements that make them better at their jobs and healthier throughout their lives. Guide dogs and service animals could be bred without the hereditary conditions that currently force many promising dogs out of training programs. If the technology proves safe and effective, and if it's made available beyond military contracts, the welfare and capability improvements could extend to working dogs across many fields.

The Ethical Questions Can't Be Ignored

Creating animals specifically designed for combat roles through genetic engineering crosses lines we haven't crossed before. We've bred dogs for thousands of years, selecting for traits we wanted, but genetic engineering is more direct, faster, and capable of changes that wouldn't occur through traditional breeding. Are we obligated to consider the animal's experience when we design it to be more aggressive, to tolerate more pain, or to perform in ways that put it in greater danger? The animals can't consent to being created for these purposes. There's also the question of what happens to gene-edited dogs that don't meet performance standards or that are retired from service. Will they be adopted into civilian homes? Are there unforeseen health or behavioral consequences of the modifications? These aren't hypothetical concerns—they're questions that need answers before the first modified puppy is born.

The Military Demand Is Clearly There

The U.S. military currently uses approximately 1,600 working dogs across all branches, with demand consistently exceeding supply. Training programs struggle to produce enough qualified animals, and many dogs wash out due to health problems or temperament issues. If Warhound can reliably produce dogs that are healthier, perform better, and last longer in service, the military market alone would justify the investment. Law enforcement agencies use thousands more K9s, and many face similar supply challenges. The $200 million in funding and the $1.2 billion valuation reflect investor confidence that this demand is real and that Warhound's approach can meet it. Whether that demand should be met through genetic engineering rather than improved breeding and training is a separate question, but the market clearly exists.

What This Means for Genetic Engineering Broadly

Warhound represents genetic engineering moving out of the laboratory and into operational, real-world applications in a very visible way. Colossal Biosciences' work on extinct species is fascinating but abstract; gene-edited military dogs are concrete and immediate. If this succeeds, it will normalize genetic modification of animals for human purposes in ways that could accelerate similar applications elsewhere—agriculture, conservation, medicine, even pets. That's not inherently good or bad, but it's a significant shift. It will force conversations about regulation, oversight, animal welfare standards, and the limits of what we should do just because we can. The technology is moving faster than our ethical frameworks and legal structures, which is often how transformative technologies work, but it means we're figuring out the rules as we go.

The Bottom Line on Gene-Edited War Dogs

This is simultaneously impressive, useful, and deeply strange. The technology could genuinely improve the lives of working dogs by eliminating painful inherited diseases and could enhance their capabilities in ways that save human lives. It could also push us into territory where we're creating sentient beings primarily as optimized tools for combat, with all the ethical complications that entails. The first gene-edited puppies will arrive in about two years, which doesn't leave much time for society to figure out how it feels about this or what guardrails should exist. The science is real, the funding is secured, and the market demand is clear. Whether this is a breakthrough in animal welfare and capability or a troubling step toward treating living beings as programmable hardware depends partly on how Warhound executes and partly on what values we decide to prioritize. What do you think—is genetically engineering working dogs for health and performance a genuine improvement, or does it cross a line we shouldn't cross?  
LATEST ARTICLES

RECENT ARTICLES

Mortgage Today (PM) – 04/21/26

April 21st, 2026|Week In Review|

--- WTMS Blog Today = What's up in Mortgage Today (PM) - 04/21/2026 Geopolitical tensions over a stalled Iran ceasefire sent mortgage-backed securities down a quarter point by afternoon close, forcing lenders to weigh repricing [...]

Read More

Mortgage Today (AM) – 04/21/26

April 21st, 2026|Week In Review|

--- WTMS Blog Today = What's up in Mortgage Today (AM) - 04/21/2026 Retail sales crushed expectations at 1.7 percent versus the 1.4 percent forecast, but Treasury investors barely blinked, treating the headline as a [...]

Read More

Article Archive

Subscribe

Send me some brain food

Subscribe
© Copyright 2019 |   Well That Makes Sense   |   All Rights Reserved
FacebookXLinkedIn
Go to Top